Epithalon supports telomere length and cellular longevity
On the vitamin-C front, its formulated with 10 percent L-ascorbic acid
As semaglutide and tirzepatide seek to expand their approved indications, e.g., potentially adding heart failure, chronic kidney disease or MASH, following several successful phase 3 trial readouts in 2023 and 2024, more pathways open up to Medicare reimbursement of AOMs within existing rules
Sermorelina and Ipamorelina are two of the stars of this field
Koureta E et al
Personal information may be accessed, used, or disclosed as described in these Terms, our Privacy Policy, and other applicable notices or consents, including as necessary to provide the Services, facilitate care, comply with legal obligations, protect rights and safety, and respond to lawful requests